Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis

The anthrax toxin is composed of three independent polypeptide chains. Successful intoxication only occurs when heptamerization of the receptor-binding polypeptide, the protective antigen (PA), allows binding of the two enzymatic subunits before endocytosis. We show that this tailored behavior is ca...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of cell biology Vol. 172; no. 2; pp. 309 - 320
Main Authors Abrami, Laurence, Leppla, Stephen H, van der Goot, F. Gisou
Format Journal Article
LanguageEnglish
Published United States Rockefeller University Press 16.01.2006
The Rockefeller University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The anthrax toxin is composed of three independent polypeptide chains. Successful intoxication only occurs when heptamerization of the receptor-binding polypeptide, the protective antigen (PA), allows binding of the two enzymatic subunits before endocytosis. We show that this tailored behavior is caused by two counteracting posttranslational modifications in the cytoplasmic tail of PA receptors. The receptor is palmitoylated, and this unexpectedly prevents its association with lipid rafts and, thus, its premature ubiquitination. This second modification, which is mediated by the E3 ubiquitin ligase Cbl, only occurs in rafts and is required for rapid endocytosis of the receptor. As a consequence, cells expressing palmitoylation-defective mutant receptors are less sensitive to anthrax toxin because of a lower number of surface receptors as well as premature internalization of PA without a requirement for heptamerization.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Abbreviations used in this paper: ßMCD, β-methylcyclodextrin; CMG2, capillary morphogenesis gene 2; DRM, detergent-resistant membrane; EF, edema factor; Endo H, endoglycosidase H; LF, lethal factor; PA, protective antigen; TEM8, tumor endothelial marker 8; Ub, ubiquitin; WT, wild type.
ISSN:0021-9525
1540-8140
DOI:10.1083/jcb.200507067